What we know about effective public engagement on CRISPR and beyond
What we know about effective public engagement on CRISPR and beyond
复制标题
DOI：
10.1073/pnas.2004835117
复制
发表时间：
2021-06-01
影响因子：
11.1
通讯作者：
Brossard, Dominique
中科院分区：
文献类型：
--
作者：
Scheufele, Dietram A.;Krause, Nicole M.;Brossard, Dominique
人类、植物和动物应用的基因编辑技术的进步导致了实验室和社会科学家以及各种社会利益相关者的呼吁，要求公众广泛参与这些新技术的决策。不幸的是，呼吁公众参与CRISPR和其他新兴技术的团体对以下内容的了解有限：1）这种参与的目标，2）参与模式以及我们从系统的社会科学评估中对其有效性的了解，以及3）如何将这些参与活动的产品与社会决策或政策制定联系起来。针对这三个领域，我们系统化了公共参与的共同目标，原则和模式。我们经验性地评估各种模式的可能成功。最后，我们概述了三条前进的道路，值得科学界密切关注，因为我们在生命2.0的世界中航行。
Advances in gene editing technologies for human, plant, and animal applications have led to calls from bench and social scientists, as well as a wide variety of societal stakeholders, for broad public engagement in the decision-making about these new technologies. Unfortunately, there is limited understanding among the groups calling for public engagement on CRISPR and other emerging technologies about 1) the goals of this engagement, 2) the modes of engagement and what we know from systematic social scientific evaluations about their effectiveness, and 3) how to connect the products of these engagement exercises to societal decision or policy making. Addressing all three areas, we systematize common goals, principles, and modalities of public engagement. We evaluate empirically the likely successes of various modalities. Finally, we outline three pathways forward that deserve close attention from the scientific community as we navigate the world of Life 2.0.